Si-Bone (SIBN) Shareholder's Equity (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shareholder's Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 52.06 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 22.98 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 49.20 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 26.10 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2.96 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.67 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 7.20 Bn |
| 10 | Si-Bone | 611.92 Mn | 471.80 Mn | 41.94 Mn | 178.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 178.94 Mn |
| Dec 31, 2025 | 177.53 Mn |
| Sep 30, 2025 | 172.13 Mn |
| Jun 30, 2025 | 170.34 Mn |
| Mar 31, 2025 | 167.26 Mn |
| Dec 31, 2024 | 166.96 Mn |
| Sep 30, 2024 | 164.97 Mn |
| Jun 30, 2024 | 164.73 Mn |
| Mar 31, 2024 | 165.54 Mn |
| Dec 31, 2023 | 169.38 Mn |
| Sep 30, 2023 | 173.60 Mn |
| Jun 30, 2023 | 177.41 Mn |
| Mar 31, 2023 | 93.96 Mn |
| Dec 31, 2022 | 98.30 Mn |
| Sep 30, 2022 | 102.83 Mn |
| Jun 30, 2022 | 110.83 Mn |
| Mar 31, 2022 | 122.44 Mn |
| Dec 31, 2021 | 134.42 Mn |
| Sep 30, 2021 | 143.62 Mn |
| Jun 30, 2021 | 154.20 Mn |
| Mar 31, 2021 | 161.67 Mn |
| Dec 31, 2020 | 169.36 Mn |
| Sep 30, 2020 | 102.03 Mn |
| Jun 30, 2020 | 107.87 Mn |
| Mar 31, 2020 | 116.27 Mn |
| Dec 31, 2019 | 63.01 Mn |
| Sep 30, 2019 | 68.96 Mn |
| Jun 30, 2019 | 77.75 Mn |
| Mar 31, 2019 | 82.76 Mn |
| Dec 31, 2018 | 90.19 Mn |
| Sep 30, 2018 | -139.43 Mn |
| Jun 30, 2018 | -135.70 Mn |
| Mar 31, 2018 | -133.17 Mn |
| Dec 31, 2017 | -129.38 Mn |